| Literature DB >> 19889052 |
Jonathan L Curry1, Victor G Prieto, Dan M Jones, Franscisco Vega, Madeleine Duvic, A Hafeez Diwan.
Abstract
Immunodeficiency-related lymphoproliferative disorders (IR-LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF-α antagonists. As far as we are aware, this is the first report of an Epstein-Barr virus-associated B-cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/Sézary syndrome.Entities:
Mesh:
Substances:
Year: 2011 PMID: 19889052 DOI: 10.1111/j.1600-0560.2009.01459.x
Source DB: PubMed Journal: J Cutan Pathol ISSN: 0303-6987 Impact factor: 1.587